N-(3-methylbutyl)hexanamide

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: N-(3-methylbutyl)hexanamide
• 化学式: C₁₁H₂₃NO
• mdl: MFCD03392934
• 分子量: 185.31
• InChiKey: MXXRWZSUIWWYAF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  13
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.909
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  N-(Hydroxymethyl)hexanamide 、 三异丁基铝 以 苯 为溶剂， 生成 N-(3-methylbutyl)hexanamide
  参考文献：
  名称：

  酰胺和相关化合物的N-烷基化

  摘要：

  DOI：

  10.1016/s0040-4039(01)93076-x

文献信息

• [EN] NOVEL KLK4 INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE KLK4
  申请人：UNIV ANTWERPEN

  公开号：WO2015144933A1

  公开（公告）日：2015-10-01

  The present invention relates to novel compounds and probes which have a common chemical structure necessary to obtain potent inhibitory activity against KLK4 and/or may be used for the detection of KLK4 peptides and their activity. It further relates to the use of these compounds and methods for inhibiting and/or detecting KLK4 activity in vitro and in vivo by making use of said probes or inhibitors. The compounds of the invention differ from prior art compounds at least in the presence of phenyl guanidine (instead of e.g. benzyl guanidine) and/or the presence of a heteroatom in the tail group, their combined presence unexpectedly leading to potent and selective KLK4 inhibitory activity.

  本发明涉及具有共同化学结构的新化合物和探针，这种结构对于获得强大的对KLK4的抑制活性是必要的，或者可用于检测KLK4肽及其活性。它进一步涉及利用这些化合物和方法通过利用所述的探针或抑制剂来抑制和/或检测体外和体内的KLK4活性。本发明的化合物与先前的化合物不同，至少在于存在苯基胍（而不是苄基胍等）和/或尾基中存在杂原子，它们的共同存在意外地导致强大和选择性的KLK4抑制活性。
• KLK4 inhibitors
  申请人：Universiteit Antwerpen

  公开号：US10017527B2

  公开（公告）日：2018-07-10

  The present invention relates to novel compounds and probes which have a common chemical structure necessary to obtain potent inhibitory activity against KLK4 and/or may be used for the detection of KLK4 peptides and their activity. It further relates to the use of these compounds and methods for inhibiting and/or detecting KLK4 activity in vitro and in vivo by making use of said probes or inhibitors. The compounds of the invention differ from prior art compounds at least in the presence of phenyl guanidine (instead of e.g. benzyl guanidine) and/or the presence of a heteroatom in the tail group, their combined presence unexpectedly leading to potent and selective KLK4 inhibitory activity.

  本发明涉及新型化合物和探针，它们具有获得对 KLK4 的强效抑制活性所需的共同化学结构和/或可用于检测 KLK4 肽及其活性。本发明还涉及这些化合物的用途，以及利用所述探针或抑制剂抑制和/或检测体外和体内 KLK4 活性的方法。本发明化合物与现有技术化合物的不同之处至少在于苯基胍（而不是苄基胍）的存在和/或尾部基团中杂原子的存在，它们的联合存在意外地导致了强效和选择性的 KLK4 抑制活性。
• NOVEL KLK4 INHIBITORS
  申请人：Universiteit Antwerpen

  公开号：US20170101427A1

  公开（公告）日：2017-04-13

  The present invention relates to novel compounds and probes which have a common chemical structure necessary to obtain potent inhibitory activity against KLK4 and/or may be used for the detection of KLK4 peptides and their activity. It further relates to the use of these compounds and methods for inhibiting and/or detecting KLK4 activity in vitro and in vivo by making use of said probes or inhibitors. The compounds of the invention differ from prior art compounds at least in the presence of phenyl guanidine (instead of e.g. benzyl guanidine) and/or the presence of a heteroatom in the tail group, their combined presence unexpectedly leading to potent and selective KLK4 inhibitory activity.
• METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
  申请人：Revolution Medicines, Inc.

  公开号：US20210405060A1

  公开（公告）日：2021-12-30

  The present disclosure provides methods and reagents useful for analyzing protein-protein interfaces such as interfaces between a presenter protein (e.g., a member of the FKBP family, a member of the cyclophilin family, or PIN1) and a target protein. In some embodiments, the target and/or presenter proteins are intracellular proteins. In some embodiments, the target and/or presenter proteins are mammalian proteins.
• N-alkylation of amides and related compounds
  作者：Anwer Basha、Steven M. Weinreb

  DOI：10.1016/s0040-4039(01)93076-x

  日期：1977.1